Related Experiment Video
Updated: May 6, 2026

Genome Editing with CompoZr Custom Zinc Finger Nucleases ZFNs
Published on: June 14, 2012
Sticky business: Rationalizing CRBN's zinc-finger targeting by molecular glues
Jonathan W Bushman1, Patrick Ryan Potts1
1Induced Proximity Platform, Amgen Research, Thousand Oaks, CA, USA.
Researchers identified human proteins with zinc fingers that can be degraded by CRBN-targeting molecular glues. This study refines rules for targeting these challenging proteins, expanding therapeutic options.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- The Cereblon (CRBN) E3 ubiquitin ligase complex is a key target for molecular glues.
- Zinc-finger proteins (ZFPs) represent a large and diverse class of human proteins, many of which are considered "difficult-to-drug" due to their structural properties.
- Understanding which ZFPs are susceptible to CRBN-mediated degradation is crucial for developing novel therapeutics.
Purpose of the Study:
- To conduct a comprehensive survey of human zinc-finger proteins.
- To identify ZFPs that are effectively degraded by CRBN-targeting molecular glues.
- To refine and expand the existing rules governing the targeting of ZFPs by molecular glues.
Main Methods:
- High-throughput screening of human ZFPs using CRBN-based molecular glues.
- Proteomic analysis to quantify protein degradation.
- Bioinformatic analysis to identify sequence and structural determinants of degradation.
Main Results:
- Identification of a subset of human ZFPs that are susceptible to CRBN-mediated degradation.
- Refinement of the sequence and structural motifs associated with ZFP degradation by molecular glues.
- Expansion of the known ZFP targets for CRBN-based therapeutic strategies.
Conclusions:
- CRBN-targeting molecular glues can effectively degrade specific human zinc-finger proteins.
- The study provides refined guidelines for designing molecular glues to target ZFPs.
- These findings advance the development of therapeutics for previously undruggable targets.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Crohn's Disease

